Correlation Between Anebulo Pharmaceuticals and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Champions Oncology, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Champions Oncology.
Diversification Opportunities for Anebulo Pharmaceuticals and Champions Oncology
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Anebulo and Champions is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Champions Oncology go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Champions Oncology
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Champions Oncology. In addition to that, Anebulo Pharmaceuticals is 1.63 times more volatile than Champions Oncology. It trades about -0.18 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.08 per unit of volatility. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Champions Oncology
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Champions Oncology |
Anebulo Pharmaceuticals and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Champions Oncology
The main advantage of trading using opposite Anebulo Pharmaceuticals and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
| Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |